Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00772772 · ClinicalTrials.gov registry record · Early Phase 1
Vitamin D Repletion in Chronic Kidney Disease
A Early Phase 1 study, sponsored by Rockefeller University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 12
- Enrollment target
NCT00772772 is a Early Phase 1 study that has completed, run by Rockefeller University. The registered enrollment target is 12 participants.
The verdict
NCT00772772, a Early Phase 1 study, has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The reason for doing this research is that people with kidney disease often suffer from heart disease. Why this happens is not fully known. A possible cause may be high blood levels of a substance made by bacteria called "endotoxin". The blood levels of this substance are high in people with medium-level kidney disease. We want to know if replacing normal amounts of Vitamin D can help lower the levels of this substance. We also want to know if replacing normal amounts of Vitamin D is associated with other changes that may help heart disease. We hope that our research will help figure out if levels of this substance can be lowered by replacing normal amounts of Vitamin D. Normal subjects are enrolled to have a 'control' set for comparison purposes.
Interventions
- DRUG Vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-03 |
| Est. Completion | 2009-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00772772
The ClinicalTrials.gov registry entry for NCT00772772 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin D3 is the first listed.
NCT00772772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00772772 about?
NCT00772772 is a clinical study titled "Vitamin D Repletion in Chronic Kidney Disease". The reason for doing this research is that people with kidney disease often suffer from heart disease. Why this happens is not fully known. A possible cause may be high blood levels of a substance made by bacteria called "endotoxin". The blood levels of this substance are high in people with medium-...
What is the current status of trial NCT00772772?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 12 participants. The study started on 2008-03. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00772772?
The interventions under investigation include: Vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT00772772?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.